Harm, hype and evidence: ELSI research and policy guidance.
| dc.contributor.author | Caulfield, Timothy | |
| dc.contributor.author | Chandrasekharan, Subhashini | |
| dc.contributor.author | Joly, Yann | |
| dc.contributor.author | Cook-Deegan, Robert | |
| dc.coverage.spatial | England | |
| dc.date.accessioned | 2014-07-17T23:46:31Z | |
| dc.date.issued | 2013 | |
| dc.description.abstract | There has been much investment in research on the ethical, legal and social issues (ELSI) associated with genetic and genomic research. This research should inform the development of the relevant policy. So far, much of the relevant policy - such as in the areas of patents, genetic testing and genetic discrimination - seems to be informed more by speculation of harm and anecdote than by available evidence. Although a quest for evidence cannot always be allowed to delay policy choice, it seems axiomatic to us that policy options are improved by the incorporation of evidence. | |
| dc.identifier | ||
| dc.identifier | gm425 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Springer Science and Business Media LLC | |
| dc.relation.ispartof | Genome Med | |
| dc.relation.isversionof | 10.1186/gm425 | |
| dc.title | Harm, hype and evidence: ELSI research and policy guidance. | |
| dc.type | Journal article | |
| pubs.author-url | ||
| pubs.begin-page | 21 | |
| pubs.issue | 3 | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Duke Science & Society | |
| pubs.organisational-group | Faculty | |
| pubs.organisational-group | Global Health Institute | |
| pubs.organisational-group | Initiatives | |
| pubs.organisational-group | Institutes and Provost's Academic Units | |
| pubs.organisational-group | University Institutes and Centers | |
| pubs.publication-status | Published online | |
| pubs.volume | 5 |
Files
Original bundle
- Name:
- Harm, hype and evidence: ELSI research and policy guidance..pdf
- Size:
- 574.82 KB
- Format:
- Adobe Portable Document Format